Venture Briefing @ Uni Basel
Date
Thursday 7. December 2023; 12:00 - 13:00
Location
Biozentrum University of Basel - Spitalstrasse 41, 4056 Basel
Register
The Venture Briefing event series is designed to help students with an intent to pursue entrepreneurship take their first steps towards building a successful company.
The event features an experienced entrepreneur from your region: Stefan Imseng, CEO & Co-Founder Aukera Therapeutics
About: Aukera Therapeutics develops novel drug classes to uniquely address unmet medical needs in mTOR-related disorders. The company emerged from the Biozentrum of the University of Basel and builds a discovery engine to target different branches of the mTOR pathway. Aukera Therapeutics was founded in 2021 and has won all three stages of Venture Kick.
Stefan will talk about his startup and share details about their journey building a successful company. He will also help answer some of your questions during the Q&A session:
- How to become an entrepreneur?
- How to validate my idea?
- How to fund my idea?
- How to find help to bring my idea to life?
You will also be introduced to different support programs available to new entrepreneurs:
- Venture Kick: up to CHF 150,000 pre-seed capital for business development
- InnoBooster: up to CHF 150,000 grant to accelerate market entry
- First Ventures: up to CHF 150,000 financial support and tailored coaching program for University of Applied Science students
Thank you to the Gebert Rüf Stiftung for supporting this event.
.jpg){kind=logo}
And our local partner Universität Basel
Get ready! Watch and get inspired:
Meet other founders supported by Gebert-Rüf-Stiftung / Venture Kick
About the TOR technology
Register for free for the Venture Briefing:
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
